Royal Bank of Canada’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Royal Bank of Canada’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24	Closed	–	–	7661
2024 Q2	$0	Buy	24 +17	+243%	+$89	﹤0.01%	7685
2024 Q1	$0	Sell	7 -7	-50%	-$53	﹤0.01%	7751
2023 Q4	$0	Buy	14 +10	+250%	+$111	﹤0.01%	7715
2023 Q3	$0	Sell	4 -16	-80%	-$389	﹤0.01%	7748
2023 Q2	$1K	Buy	+20	New	+$798	﹤0.01%	7128
2023 Q1	–	Hold	0	–	–	–	7611
2022 Q4	–	Sell	-11	Closed	-$299	–	7869
2022 Q3	$0	Buy	+11	New	+$387	﹤0.01%	7994
2022 Q2	–	Sell	-31	Closed	-$3K	–	7827
2022 Q1	$3K	Sell	31 -201	-87%	-$30.5K	﹤0.01%	7419
2021 Q4	$45K	Buy	232 +179	+338%	+$27.9K	﹤0.01%	6434
2021 Q3	$10K	Buy	+53	New	+$13.5K	﹤0.01%	6970

Other funds holding TBIO

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Royal Bank of Canada's TBIO Position: Q3 2024 in Review

Royal Bank of Canada sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 24 shares.

Royal Bank of Canada first reported a position in TBIO in Q3 2021 and held it in 9 quarters. The position peaked at $45K in Q4 2021. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

Royal Bank of Canada reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Royal Bank of Canada sold 24 Telesis Bio, Inc. Common Stock shares in Q3 2024.
Royal Bank of Canada first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Royal Bank of Canada's Telesis Bio, Inc. Common Stock position peaked at $45K in Q4 2021.
1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.